Kastritis, E <br/><br/>
Osteoprotegerin is a significant prognostic factor for overall survival in patients with primary systemic amyloidosis independent of the Mayo staging.  [electronic resource] 

 -  Blood cancer journal  Jun 2015 
 - e319 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2044-5385 
<br/><br/><label>Standard No.: </label>10.1038/bcj.2015.45  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Amyloidosis--metabolism<br/>Biomarkers--analysis<br/>Bone Remodeling--physiology<br/>Bone and Bones--metabolism<br/>Female<br/>Humans<br/>Immunoglobulin Light-chain Amyloidosis<br/>Male<br/>Middle Aged<br/>Osteoprotegerin--metabolism<br/>Prognosis